Xcout IntelBioSplice Therapeutics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to BioSplice Therapeutics, Inc. among biotechnology companies — ranked by similarity to what BioSplice Therapeutics, Inc. actually does, not by market-cap band.
Subscribe to see BioSplice Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About BioSplice Therapeutics, Inc.
Biosplice Therapeutics, Inc., formerly known as Samumed, LLC, is a private biopharmaceutical company based in San Diego, California. The company focuses on clinical developments such as pivotal trials for knee osteoarthritis.
BioSplice Therapeutics, Inc. at a glance
BioSplice Therapeutics, Inc. is a biotechnology company headquartered in United States. It has raised at least $340M across the 3 funding rounds on record, 2 of them with a disclosed amount. Its most recent funding round closed in August 2022. Xcout tracks 4 named people at BioSplice Therapeutics, Inc., including Erich Horsley (Chief Executive Officer).
BioSplice Therapeutics, Inc. leadership
- Erich HorsleyChief Executive Officer
- Finian TanFounder and Chairman, Vickers Venture Partners
- Osman KibarFounder and Executive Chairman, Biosplice Therapeutics
- Osman KibarFounder
BioSplice Therapeutics, Inc. funding rounds
At least $340M raised across the 3 rounds on record (2 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | Undisclosed | — | |
| Venture Round | $120M | — | |
| Series A | $220M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 BioSplice Therapeutics, Inc. competitors
Ranked by semantic similarity — how close each company is to BioSplice Therapeutics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Amplicore Inc. develops injectable therapeutics aimed at treating degenerative musculoskeletal disorders such as osteoarthritis, cartilage damage, degenerative disc disease, and acute meniscus tears. The company focuses on regenerative and minimally invasive approaches to address the underlying causes of joint discomfort and restore mobility for patients.
Similar biotechnology company
Kenai Therapeutics is a clinical-stage biotechnology company headquartered in San Diego, California. The company pioneers next-generation therapeutic approaches by leveraging induced pluripotent stem cell (iPSC) technology.
Biotech
SpliceBio is a clinical-stage genetic medicines company that develops gene therapies using a proprietary Protein Splicing platform. The company focuses on treating diseases caused by mutations in large genes, with a lead clinical program targeting Stargardt disease.
Similar biotechnology company
SpinalCyte is a U.S. biotechnology company developing regenerative, cell-based therapies for spinal disorders, particularly degenerative disc disease. Its work has focused on injectable allogeneic cell therapies intended to repair or regenerate damaged intervertebral discs, serving patients with spinal degeneration.
Biotech
VitaSpring Biomedical Co. Ltd. specializes in pioneering pharmaceutical solutions derived from cellular medicine. It previously operated as Shemn Corp. before rebranding as VitaSpring Biomedical Co. Ltd. in February 2020. The company was established in 2016 and its main operations are based in Irvine, California.
Life Sciences (Therapeutics)
DTx Pharma, Inc. is a privately held biotechnology company based in San Diego, California, that addresses the challenges associated with delivering RNA-based therapeutics.
Similar biotechnology company
VST Bio Corp. is a leader in the development of innovative biologics to treat acute and chronic cardiovascular diseases. Headquartered in San Diego, California, the company engages in drug pipelines, patents, and clinical trials.
Biotech
Quince Therapeutics, Inc. (QNCX) operates as a biopharmaceutical firm dedicated to developing targeted treatments for debilitating and rare diseases. A cornerstone of their innovation is an extensive bone-targeting drug delivery platform, engineered to accurately transport diverse therapeutic agents, such as small molecules, peptides, and large molecules, directly to affected bone areas like fractures and disease sites. Leading their pipeline is NOV004, an anabolic peptide meticulously designed to pinpoint and accumulate its therapeutic action precisely at bone fracture locations. The company, previously known as Cortexyme, Inc., officially rebranded as Quince Therapeutics, Inc. in August 2022. Established in 2012, Quince Therapeutics is headquartered in South San Francisco, California.
Similar biotechnology company
ADARx Pharmaceuticals, Inc. is a clinical-stage biotechnology company located in San Diego, California. The company is committed to developing cutting-edge RNA-targeted therapeutics to treat various genetic and severe diseases. ADARx focuses on translating scientific research into life-saving medicines through its proprietary drug discovery pipeline.
Similar biotechnology company
cAMPfield Therapeutics is a biotechnology research company headquartered in San Diego, California. The company focuses on discovering and developing innovative therapeutic treatments targeting specific biological pathways.
Biotech
Abilita Therapeutics, Inc. is a privately held biotechnology company founded in 2014 and focused on redefining therapeutics. The company is headquartered in San Diego, California.
Similar biotechnology company
Cellics Therapeutics, Inc. is a privately held biotechnology company headquartered in San Diego, California, developing novel therapeutic products.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of BioSplice Therapeutics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for BioSplice Therapeutics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →